Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins
- 15 November 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (10) , 1310-1312
- https://doi.org/10.1016/j.amjcard.2004.07.122
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practiceThe American Journal of Medicine, 2002
- Tachyphylaxis in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsThe American Journal of Cardiology, 2001
- Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countriesThe Lancet, 2001
- HMG-CoA reductase inhibitorsAdvances in Protein Chemistry, 2001
- Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible united states adultsThe American Journal of Cardiology, 1998
- Comparison of Statins in HypertriglyceridemiaThe American Journal of Cardiology, 1998
- The Treatment Gap in Coronary Artery Disease and Heart Failure: Community Standards and the Post-Discharge PatientThe American Journal of Cardiology, 1997
- Inadequate treatment with HMG-CoA reductase inhibitors by health care providersThe American Journal of Medicine, 1996